NRG1 and lung carcinoma: By applying rhNRG1 and NRG1 neutralizing antibody, both sphere formation assay and stemness-related gene examination revealed that CAFs facilitated lung cancer cell stemness under osimertinib treatment via NRG1 (Figure 5H-J).